Teleflex Declares a Quarterly Cash Dividend
Teleflex Incorporated (NYSE: TFX), a leader in medical technology, recently made an important announcement regarding its financial returns to shareholders. The Board of Directors has declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. This decision reflects the company's strong financial position and commitment to providing value to its investors.
Details of the Dividend Payment
Shareholders can expect to receive this dividend on September 15, 2025. To qualify, they must be on record as shareholders by the close of business on August 15, 2025. Such regular dividends are a sign of a well-managed company and instill confidence in current and prospective investors.
About Teleflex and Its Commitment to Healthcare
Teleflex is not just about dividends; it is a global provider of groundbreaking medical technologies. The company is driven by its purpose of enhancing the health and quality of life for people around the world. With a vision to be the most trusted partner in the healthcare sector, Teleflex offers a diverse range of solutions. These solutions are aimed at various critical therapy areas such as anesthesia, emergency medicine, interventional cardiology, and surgical care.
The Impact of Teleflex Products
Among the brands under Teleflex are Arrow™, Barrigel™, Deknatel™, LMA™, Pilling™, QuikClot™ Rüsch™, UroLift™, and Weck™. Each of these brands is united by the common goal of improving patient outcomes and streamlining medical procedures. The company’s dedication to purpose-driven innovation continues to make significant advancements in healthcare.
Empowering the Future of Healthcare
Teleflex's dedication to innovative solutions doesn’t stop with their established products. They continuously invest in research and development, aiming to deliver cutting-edge technologies that address the evolving needs of healthcare professionals and patients alike. This proactive approach is crucial as the landscape of healthcare shifts, and the demand for efficient, effective medical solutions grows.
Contacting Teleflex
Those interested in learning more about Teleflex’s offerings or want to discuss investor relations can reach out to the company directly. Lawrence Keusch, the Vice President of Investor Relations and Strategy Development, is the main contact for these inquiries. Teleflex welcomes engagement and offers a comprehensive view of their mission and product line through their investor relations.
Frequently Asked Questions
What is the declared amount for the quarterly dividend?
The quarterly dividend declared by Teleflex is thirty-four cents ($0.34) per share.
When will the dividend be payable?
The dividend will be payable on September 15, 2025, to shareholders on record as of August 15, 2025.
What sectors does Teleflex serve?
Teleflex provides medical solutions in sectors such as anesthesia, emergency medicine, interventional cardiology, and urology.
What brands are part of Teleflex's portfolio?
Teleflex's brands include Arrow™, Barrigel™, Deknatel™, and QuikClot™ Rüsch™, among others, each aimed at improving healthcare outcomes.
How can I contact Teleflex for investor relations?
Investors can contact Lawrence Keusch at Teleflex for any inquiries related to investor relations through their provided contact details.
